New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 9, 2009
07:14 EDTCYTX
theflyonthewall.com: Cytori Therapeutics reports Q3 EPS (18c) vs. consensus of (15c)
Reports Q3 revenue $1.38M vs. consensus of 2.63M. :theflyonthewall.com



News For CYTX From The Last 14 Days
Check below for free stories on CYTX the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2012
08:05 EDTCYTX
theflyonthewall.com: Cytori receives approval from FDA to initiate U.S. cardiac cell therapy trial
Cytori Therapeutics has received an Investigational Device Exemption, IDE, approval from the U.S. FDA to begin the ATHENA trial. ATHENA will investigate the use of the Celution® System, an innovative medical device to prepare adipose-derived stem and regenerative cells, ADRCs, to treat a form of coronary heart disease, chronic myocardial ischemia, CMI. The IDE application was originally submitted to the FDA in December 2011. :theflyonthewall.com